Study of heart function years after breast cancer treatment
Part of Cancer, Heart & circulation, Injuries & trauma, Skin clinical trials.
This study checks how well your heart works long after breast cancer treatment. If you joined the earlier de BLOC-I study, you may be invited for follow-up to understand long-term heart effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have taken part in the earlier de BLOC-I breast cancer study.
- You were a woman diagnosed with breast cancer stage I to III at least 5 years ago (or you had a local/nearby recurrence at least 5 years ago).
- You previously received chemotherapy and/or radiation therapy for breast cancer.
- You must be able to travel to the study hospital; severe physical or mental illness that prevents travel may disqualify you (decided by your GP).
- You generally must not have had metastatic (spread to distant parts) breast cancer at the time of your diagnosis.
- You generally must not have had any cancer treatment after age 80, and you generally must not have been treated for a different type of cancer in the past.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study watches how chemotherapy and HER2-targeted drugs affect your heart during early-stage breast cancer treatment. Researchers use heart scans to catch any changes early and understand how to protect heart health.
This study tests if a 12-week exercise program improves heart health in women over 60 who have finished treatment for early-stage breast cancer. You will be placed in either an aerobic exercise group or a stretching group to see which helps your heart more.
This trial is checking if a simple blood test (NT-proBNP) can help spot early signs of heart side effects from certain breast cancer treatments (chemotherapy plus HER2 blockers). If successful, it might help doctors adjust treatment sooner to protect your heart.
This study tests a structured heart rehabilitation program for people who have had cancer treatment. It aims to improve heart health and reduce cardiovascular problems in cancer survivors.
This study uses heart ultrasound (echocardiogram) to find early signs of heart damage from breast cancer treatment. It aims to better protect your heart during and after therapy.
This study helps doctors find the best way to monitor heart health in women with HER2-positive breast cancer who are receiving a type of targeted chemotherapy. The goal is to catch any heart problems early and keep you safe during treatment.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.